Boston Epigenetics Society (BES) Meeting Feb 2024- Samir Ounzain, HAYA Therapeutics

Поделиться
HTML-код
  • Опубликовано: 29 фев 2024
  • Recording of the Boston Epigenetics Society (BES) online meeting February 29, 2024 with Samir Ounzain, Ph.D., CEO and Co-Founder of HAYA Therapeutics.
    "Unlocking the Regulatory Genome: Pioneering RNA-Guided Therapeutics for Cell-State Modulation in Disease Pathogenesis"

Комментарии • 2